Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.94% of ...
On Friday, Ocular Therapeutix Inc (OCUL) stock saw a decline, ending the day at $8.68 which represents a decrease of $-0.10 or -1.14% from the prior close of $8.78. The stock opened at $8.89 and ...